Cargando…

Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation

INTRODUCTION: Assessment of fluid status in critically ill patients is challenging. We aimed to assess the feasibility and validity of bioelectrical impedance vector analysis (BIVA) as a measure of hydration in critically ill patients. METHODS: We performed twice-daily BIVA measurements and fluid ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Sarah L., Tanaka, Aiko, Eastwood, Glenn M., Young, Helen, Peck, Leah, Bellomo, Rinaldo, Mårtensson, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531396/
https://www.ncbi.nlm.nih.gov/pubmed/26260579
http://dx.doi.org/10.1186/s13054-015-1009-3
_version_ 1782385033141551104
author Jones, Sarah L.
Tanaka, Aiko
Eastwood, Glenn M.
Young, Helen
Peck, Leah
Bellomo, Rinaldo
Mårtensson, Johan
author_facet Jones, Sarah L.
Tanaka, Aiko
Eastwood, Glenn M.
Young, Helen
Peck, Leah
Bellomo, Rinaldo
Mårtensson, Johan
author_sort Jones, Sarah L.
collection PubMed
description INTRODUCTION: Assessment of fluid status in critically ill patients is challenging. We aimed to assess the feasibility and validity of bioelectrical impedance vector analysis (BIVA) as a measure of hydration in critically ill patients. METHODS: We performed twice-daily BIVA measurements and fluid balance calculations and recorded physiological variables in mechanically ventilated patients within 24 h of intensive care unit (ICU) admission for up to 5 days. Treating clinicians were blinded to BIVA results. RESULTS: We performed 344 BIVA measurements in 61 patients. According to BIVA, 14 patients (23 %) were dehydrated, 22 (36 %) were normally hydrated and 25 (41 %) were overhydrated upon ICU admission. Patients with normal BIVA hydration were less sick, had fewer comorbidities and had less deranged physiology than patients found to be dehydrated or overhydrated with BIVA. Cumulative fluid balance increased in patients found to be dehydrated with BIVA by a mean of 3.4±2.2 L, whereas in patients found to be overhydrated with BIVA, it decreased by a mean of 4.5±6.9 L. In patients found to be normally hydrated with BIVA, fluid balance remained unchanged. BIVA-defined hydration increased with 1 L (median change 1.5 %, P =0.09) or 2 L (median change 0.7 %, P =0.09) of calculated fluid gains. BIVA-defined hydration decreased (median change −0.8 %, P =0.02) with a negative cumulative fluid balance of >2 L. BIVA-defined hydration between first and last measurement correlated with the corresponding change in fluid balance (ρ =0.25, P =0.05). CONCLUSIONS: BIVA is feasible in critically ill patients. Its validity is supported by the observed characteristics of patients with different degrees of BIVA hydration upon admission and by different fluid management of such patients by blinded clinicians. The sensitivity of repeated BIVA hydration measurements to detect fluid accumulation or fluid balance changes <2 L was low, however. These contradictory findings provide the rational basis for studies of BIVA-assisted fluid management in ICU patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-1009-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4531396
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45313962015-08-12 Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation Jones, Sarah L. Tanaka, Aiko Eastwood, Glenn M. Young, Helen Peck, Leah Bellomo, Rinaldo Mårtensson, Johan Crit Care Research INTRODUCTION: Assessment of fluid status in critically ill patients is challenging. We aimed to assess the feasibility and validity of bioelectrical impedance vector analysis (BIVA) as a measure of hydration in critically ill patients. METHODS: We performed twice-daily BIVA measurements and fluid balance calculations and recorded physiological variables in mechanically ventilated patients within 24 h of intensive care unit (ICU) admission for up to 5 days. Treating clinicians were blinded to BIVA results. RESULTS: We performed 344 BIVA measurements in 61 patients. According to BIVA, 14 patients (23 %) were dehydrated, 22 (36 %) were normally hydrated and 25 (41 %) were overhydrated upon ICU admission. Patients with normal BIVA hydration were less sick, had fewer comorbidities and had less deranged physiology than patients found to be dehydrated or overhydrated with BIVA. Cumulative fluid balance increased in patients found to be dehydrated with BIVA by a mean of 3.4±2.2 L, whereas in patients found to be overhydrated with BIVA, it decreased by a mean of 4.5±6.9 L. In patients found to be normally hydrated with BIVA, fluid balance remained unchanged. BIVA-defined hydration increased with 1 L (median change 1.5 %, P =0.09) or 2 L (median change 0.7 %, P =0.09) of calculated fluid gains. BIVA-defined hydration decreased (median change −0.8 %, P =0.02) with a negative cumulative fluid balance of >2 L. BIVA-defined hydration between first and last measurement correlated with the corresponding change in fluid balance (ρ =0.25, P =0.05). CONCLUSIONS: BIVA is feasible in critically ill patients. Its validity is supported by the observed characteristics of patients with different degrees of BIVA hydration upon admission and by different fluid management of such patients by blinded clinicians. The sensitivity of repeated BIVA hydration measurements to detect fluid accumulation or fluid balance changes <2 L was low, however. These contradictory findings provide the rational basis for studies of BIVA-assisted fluid management in ICU patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-1009-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-12 2015 /pmc/articles/PMC4531396/ /pubmed/26260579 http://dx.doi.org/10.1186/s13054-015-1009-3 Text en © Jones et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jones, Sarah L.
Tanaka, Aiko
Eastwood, Glenn M.
Young, Helen
Peck, Leah
Bellomo, Rinaldo
Mårtensson, Johan
Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
title Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
title_full Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
title_fullStr Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
title_full_unstemmed Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
title_short Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
title_sort bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531396/
https://www.ncbi.nlm.nih.gov/pubmed/26260579
http://dx.doi.org/10.1186/s13054-015-1009-3
work_keys_str_mv AT jonessarahl bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation
AT tanakaaiko bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation
AT eastwoodglennm bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation
AT younghelen bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation
AT peckleah bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation
AT bellomorinaldo bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation
AT martenssonjohan bioelectricalimpedancevectoranalysisincriticallyillpatientsaprospectiveclinicianblindedinvestigation